4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001229765-26-000008
Director sold 52,084 shares at $20.18 ($1,051,055)
- Director acquired 52,084 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
GRIFFIN MICHELLE RENEE · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-25 | Exercise or conversion : show line 1 in the form 10b5-1 | +52,084 | $7.80 | $406,255 | 67,709 | D |
| 2026-06-25 | Sale : show line 2 in the form 10b5-1 | −52,084 | $20.18 | $1,051,055 | 15,625 | D |
| Open-market sales · 52,084 sh · avg $20.18 · $1,051,055 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-25 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −52,084 | 0 | D |
Loading xslF345X06/form4.xml…